Skip to main content
Morning Star Conference
Concerns raised over privacy and ethics of Israel-Pfizer vaccine deal
A health care professional prepares a Pfizer-BioNTech COVID-19 vaccine at Sheba Tel Hashomer Hospital in Ramat Gan, Israel, Tuesday, Jan. 12, 2021

CONCERNS have been raised over the ethics of a data-sharing deal between Israel and pharmaceutical company Pfizer in the latest controversy to hit its vaccine roll-out.

Israel’s denial of vaccinations to Palestinians living under military occupation in the West Bank has been condemned as a breach of the Geneva conventions.

But now authorities are also under fire for a deal by which Prime Minister Benjamin Netanyahu promised to share swathes of medical data with Pfizer in return for faster delivery of vaccine doses.

Supporters of the deal say a meticulous study of Israel’s vaccination success will benefit all countries.

But the exact quid pro quo between Israel and Pfizer is unclear, even after a redacted version of the agreement  was published by the Israeli Health Ministry on Sunday. 

Privacy Israel said the handling and security of private data was an issue, while the World Health Organisation has called on drug producers and wealthy countries to “stop making bilateral deals” that undermine efforts to provide the vaccine to citizens of poorer nations.

The 95th Anniversary Appeal
Support the Morning Star
You have reached the free limit.
Subscribe to continue reading.
More from this author
The Morning Star AGM in Salford
Features / 7 June 2025
7 June 2025

Editor BEN CHACKO explains why next weekend’s Morning Star conference is not to be missed

Your Paper / 28 May 2025
28 May 2025

Our roving AGM from this Thursday through Sunday and our upcoming Morning Star Conference 2025 on June 14 in London are great opportunities to meet the team and help plan the way forward, says editor BEN CHACKO